Antifungal agents: In vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy : Antimicrobial pharmacokinetics and pharmacodynamics for the clinicianGROLL, A. H; KOLVE, H.European journal of clinical microbiology & infectious diseases (Print). 2004, Vol 23, Num 4, pp 256-270, issn 0934-9723, 15 p.Article

Five-year-survey of invasive aspergillosis in a paediatric cancer centre. epidemiology, management and long-term survivalGROLL, A. H; KURZ, M; SCHNEIDER, W et al.Mycoses. 1999, Vol 42, Num 7-8, pp 431-442, issn 0933-7407Article

Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbitsPETRAITIS, V; PETRAITIENE, R; GROLL, A. H et al.Antimicrobial agents and chemotherapy. 1998, Vol 42, Num 11, pp 2898-2905, issn 0066-4804Article

Fortschritte in Prävention und Therapie infektiöser Komplikationen bei Kindern und Jugendlichen mit neoplastischen Erkrankungen = Advances in prevention and treatment of infectious complications in children and adolescents with cancerGROLL, A. H; MÜLLER, F.-M. C.Klinische Pädiatrie. 1998, Vol 210, Num 3, pp 106-114, issn 0300-8630Article

ESCMID^* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDSLORTHOLARY, O; PETRIKKOS, G; CUENCA-ESTRELLA, M et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 7, pp 68-77, issn 1470-9465, 10 p.Article

ESCMID^* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida sppHOPE, W. W; CASTAGNOLA, E; CUENCA-ESTRELLA, M et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 7, pp 38-52, issn 1470-9465, 15 p.Article

ESCMID^* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)ULLMANN, A. J; AKOVA, M; CORNELY, O. A et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 7, pp 53-67, issn 1470-9465, 15 p.Article

Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosisTRAGIANNIDIS, A; GROLL, A. H.Clinical microbiology and infection. Supplement. 2009, Vol 15, Num 5, pp 82-86, issn 1470-9465, 5 p.Conference Paper

Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbitsPETRAITIENE, R; PETRAITIS, V; GROLL, A. H et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 9, pp 2148-2155, issn 0066-4804Article

Compartmental pharmacokinetics and tissue drug distribution of the pradimicin derivative BMS 181184 in rabbitsGROLL, A. H; SEIN, T; PETRAITIS, V et al.Antimicrobial agents and chemotherapy. 1998, Vol 42, Num 10, pp 2700-2705, issn 0066-4804Article

Trends in the postmortem epidemiology of invasive fungal infections at a University HospitalGROLL, A. H; SHAH, P. M; MENTZEL, C et al.The Journal of infection. 1996, Vol 33, Num 1, pp 23-32, issn 0163-4453Article

ESCMID^* guideline for the diagnosis and management of Candida diseases 2012: diagnostic proceduresCUENCA-ESTRELLA, M; VERWEIJ, P. E; BASSETTI, M et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 7, pp 9-18, issn 1470-9465, 10 p.Article

Trends in the postmortem epidemiology of invasive fungal infections at a university hospitalLEHRNBECHER, T; FRANK, C; ENGELS, K et al.The Journal of infection. 2010, Vol 61, Num 3, pp 259-265, issn 0163-4453, 7 p.Article

Empfehlungen zur Prävention der Pneumocystis-carinii-Pneumonie bei Kindern und Jugendlichen mit neoplastischen Erkrankungen = Guidelines for prevention of Pneumocystis carinii pneumonitis in children and adolescents with cancerGROLL, A. H; RITTER, J; MÜLLER, F.-M. C et al.Klinische Pädiatrie. 2001, Vol 213, pp A38-A49, issn 0300-8630, SUP1Article

Prävention von Pilzinfektionen bei Kindern und Jugendlichen mit neoplastischen Erkrankungen = Prevention of fungal infections in children and adolescents with cancerGROLL, A. H; RITTER, J; MÜLLER, F.-M. C et al.Klinische Pädiatrie. 2001, Vol 213, pp A50-A68, issn 0300-8630, SUP1Article

Esophageal candidiasis in pediatric acquired immunodeficiency syndrome : clinical manifestations and risk factorsCHIOU, C. C; GROLL, A. H; GONZALEZ, C. E et al.The Pediatric infectious disease journal. 2000, Vol 19, Num 8, pp 729-734, issn 0891-3668Article

Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbitsGROLL, A. H; PETRAITIS, V; PETRAITIENE, R et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 10, pp 2463-2467, issn 0066-4804Article

Current approaches to diagnosis and treatment of fungal infections in children infected with human immuno deficiency virusMÜLLER, F.-M. C; GROLL, A. H; WALSH, T. J et al.European journal of pediatrics. 1999, Vol 158, Num 3, pp 187-199, issn 0340-6199Article

Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits : efficacy, safety and non-compartmental pharmacokineticsGROLL, A. H; GONZALEZ, C. E; GIRI, N et al.Journal of antimicrobial chemotherapy (Print). 1999, Vol 43, Num 1, pp 95-103, issn 0305-7453Article

High-performance liquid chromatographic determination of liposomal nystatin in plasma and tissues for pharmacokinetic and tissue distribution studiesGROLL, A. H; MICKIENE, D; WERNER, K et al.Journal of chromatography. B, Biomedical sciences and applications. 1999, Vol 735, Num 1, pp 51-62, issn 1387-2273Article

Antifungal activity of the pradimicin derivative BMS 181184 in the treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbitsGONZALEZ, C. E; GROLL, A. H; GIRI, N et al.Antimicrobial agents and chemotherapy. 1998, Vol 42, Num 9, pp 2399-2404, issn 0066-4804Article

Use of linezolid in neonatal and pediatric inpatient facilities—results of a retrospective multicenter surveySIMON, A; MÜLLENBORN, E; DOHNA-SCHWAKE, C et al.European journal of clinical microbiology & infectious diseases (Print). 2012, Vol 31, Num 7, pp 1435-1442, issn 0934-9723, 8 p.Article

ESCMID^* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patientsCORNELY, O. A; BASSETTI, M; BILLE, J et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 7, pp 19-37, issn 1470-9465, 19 p.Article

Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patientsBOCHENNEK, K; TRAMSEN, L; SCHEDLER, N et al.Clinical microbiology and infection. 2011, Vol 17, Num 12, pp 1868-1874, issn 1198-743X, 7 p.Article

Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia : analysis of the multicenter clinical trial AML-BFM 93LEHRNBECHER, T; KAISER, J; VARWIG, D et al.European journal of clinical microbiology & infectious diseases (Print). 2007, Vol 26, Num 10, pp 735-738, issn 0934-9723, 4 p.Article